|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1995-10-6
|
|
pubmed:abstractText |
The primary goal of this study was to assess the effectiveness of interferon gamma (IFN-gamma) to prevent tumor relapse following potentially curative surgery in patients with high-risk colon cancer. A secondary goal was to determine the effect of IFN-gamma on immune function and to correlate alterations in immune parameters with survival.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2324-9
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:7666090-Adult,
pubmed-meshheading:7666090-Aged,
pubmed-meshheading:7666090-Aged, 80 and over,
pubmed-meshheading:7666090-Colonic Neoplasms,
pubmed-meshheading:7666090-Combined Modality Therapy,
pubmed-meshheading:7666090-Female,
pubmed-meshheading:7666090-Follow-Up Studies,
pubmed-meshheading:7666090-HLA-DR Antigens,
pubmed-meshheading:7666090-Humans,
pubmed-meshheading:7666090-Interferon-gamma,
pubmed-meshheading:7666090-Male,
pubmed-meshheading:7666090-Middle Aged,
pubmed-meshheading:7666090-Monocytes,
pubmed-meshheading:7666090-Multivariate Analysis,
pubmed-meshheading:7666090-Neoplasm Recurrence, Local,
pubmed-meshheading:7666090-Postoperative Care,
pubmed-meshheading:7666090-Proportional Hazards Models,
pubmed-meshheading:7666090-Prospective Studies,
pubmed-meshheading:7666090-Receptors, Fc,
pubmed-meshheading:7666090-Regression Analysis
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Controlled clinical trial of interferon-gamma as postoperative surgical adjuvant therapy for colon cancer.
|
|
pubmed:affiliation |
Cedar Rapids Oncology Project Community Clinical Oncology Program, IA, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|
